Quick Answer
Liminatus Pharma, Inc. reported Total Assets of $512.8 thousand for the year ending 2025.
- Liminatus Pharma, Inc. showed a decrease of -90.5% in Total Assets from 2024 to 2025.
- This data is from Liminatus Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2025: $1.91 million | Q3 2025: $1.34 million.
- Historical annual values: Fiscal year 2025: $512.8 thousand | Fiscal year 2024: $5.41 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: